Detection of clopidogrel resistance by MEA and LTA

Transfuze a Hematologie Dnes

Volumn 17, Issue 2, 2011, Pages 92-96

  Slavik, Luděk ^a   Ulehlova, J ^a   Krcova, V ^a   Hlusi, A ^a   Indrakova, J ^a   Hutyra, M ^a   Galuszka, J ^a   Indrak, K ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Antiplatelet therapy; Clopidogrel; Multiple electrode aggregometry; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PROSTAGLANDIN E1;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; LABORATORY TEST; LIGHT TRANSMISSION AGGREGOMETRY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE PLATELET AGGREGOMETRY; SENSITIVITY ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

EID: 80052617784     PISSN: 12135763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Michelson AD, Cattaneo M, Eikelboom JW, et al. Platelet physiology subcommittee of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis; working group on aspirin resistance. Aspirin resistance: Position paper of the working group on aspirin resistance. J Thromb Haemost 2005;3(6):1309-1311.
2. Lau WC, Gurbel PA, Watkins PB, et al. Contribution of hepatic cytochrome P450-3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 2004;109:166-171. (Pubitemid 38114134)
3. Savi P, Combalbert J, Gaich C, et al. The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A. Thromb Haemost 1994;72:313-317. (Pubitemid 24251300)
4. Gurbel PA, Bliden KP, Zaman KA, et al. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: Results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation 2005;111:1153-1159. (Pubitemid 40365477)
5. Hermann A, Rauch BH, Braun M, et al. Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001;12:74-82. (Pubitemid 32281113)
6. Xiao Z, Theroux P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 2004;43:1982-1988. (Pubitemid 38686790)
7. Gurbel PA, Bliden KP, Tantry US. The effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: Results of the CLEAR PLATELETS-Ib study. J Am Coll Cardiol 2006;48(11):2186-91. (Pubitemid 44855418)
8. Sage SO, Rink TJ. The kinetics of changes in intracellular calcium concentration in Fura-2-loaded human platelets. J Biol Chem 1987;262, pp. 16364-16369. (Pubitemid 18006059)
9. 2+ influx in fura-2-loaded human platelets. Biochem J 1990;265, pp. 675-680.
10. Mani H, Kirchmayr K, Klaffling C, et al. Influence of blood collection techniques on platelet function. Platelets 15:315-318.
11. Linnemann B, Schwonberg J, Mani H, et al. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008;6:677-683. (Pubitemid 351404936)
12. Cattaneo M, Lecchi A, Zighetti ML, et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet rich plasma to normalize platelet count. Haematologica 2007;92:694-697. (Pubitemid 350144275)
13. Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-126.
14. Seyfert UT, Haubelt H, Vogt A, et al. Variables influencing Multiplate (TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206. (Pubitemid 46744118)
15. Mueller T, Dieplinger B, Poelz W, et al. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer-comparison with two flow cytometric methods. Thromb Res 2007;121:249-258. (Pubitemid 350148206)
16. Davdì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;13;357(24):2482-94.
17. Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost 2008;100(1):76-82. (Pubitemid 351948748)
18. *2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel. Thromb J 2011;22;9(1):4.
19. Momary KM, Dorsch MP, Bates ER. Genetic causes of clopidogrel nonresponsiveness: which ones really count? Pharmacotherapy 2010;30(3):265-74.
20. Motovska Z, Kvasnicka J, Hajkova J, Kala P, Simek S, Bobcikova P, Petr R, Bilkova D, Poloczek M, Miklik R, Fischerova M, Maly M, Widimsky P. Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial. Atherosclerosis 2010;212(2):548-52.
21. Neubauer H, Lask S, Engelhardt A, et al. How to optimise clopidogrel therapy? Reducing the low response incidence by aggregometry-guided therapy modification. Thromb Haemost 2008;99:357-362. (Pubitemid 351230967)
22. Siller-Matula J, Schrör K, Wojta J, et al. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost 2007;97:385-393. (Pubitemid 46437800)
23. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel. Clinical implications, management, and future perspectives. J Am Coll Cardiol 2007;49:1505-1516. (Pubitemid 46517957)